Catalyst Wire Dossier Catalyst Wire Dossier

MESALAMINE (generic)

Mesalamine · Actavis Pharma, Inc.
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for MESALAMINE (generic), covering 2018-03-23 to 2021-07-15. Get the full timeline:

Most recent: FDA Approved: MESALAMINE — Original Application (Ascend Laboratories, LLC)

See pricing